Lucira

Lucira's diagnostic is the first over-the-counter at-home combination test for COVID-19 and flu authorized by the FDA.

Lucira's molecular testing kit allows individuals to collect their own nasal sample and insert it into a device that provides results in under 30 minutes. The company is aiming to sell the single-use tests for roughly $50.